{"id":70705,"date":"2026-05-12T09:29:41","date_gmt":"2026-05-12T09:29:41","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70705"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"oxytocin-acetate","status":"publish","type":"product","link":"https:\/\/medsbase.com\/de\/product\/oxytocin-acetate\/","title":{"rendered":"Oxytocin Acetat"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Kurze Antwort \u2014 Was ist Oxytocin-Acetat?<\/h3>\n<p style=\"margin: 0;\"><strong>Oxytocin Acetat<\/strong> is the acetate-salt form of oxytocin, a 9-amino-acid cyclic neuropeptide with a single disulfide bridge between Cys1 and Cys6. It is one of the oldest and most extensively studied neuropeptides in published studies, acting as both a hypothalamic hormone (uterine contraction, milk ejection) and a central neuromodulator of social bonding, trust, and affiliative behaviour. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Was Sie bei MedsBase erhalten:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/de\/reviews\/\">Kundenbewertungen<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Jede Bestellung ist durch unsere <a href=\"https:\/\/medsbase.com\/de\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> abgedeckt \u2014 wenn Ihr Paket nicht innerhalb von 20 Werktagen ankommt, versenden wir es erneut.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Spezifikation<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS-Nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">50-56-6 (Oxytocin freie Base); geliefert als Acetat-Salzform<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekularformel<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>43<\/sub>H<sub>66<\/sub>N<sub>12<\/sub>O<sub>12<\/sub>S<sub>2<\/sub> (freie Base; Acetat-Salz f\u00fcgt CH<sub>3<\/sub>COOH-Gegenion hinzu)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekulargewicht<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1007.19 Da (freie Base)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenz<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH<sub>2<\/sub> (CYIQNCPLG-NH<sub>2<\/sub>, 9 Aminos\u00e4uren; intramolekulare Disulfidbr\u00fccke Cys<sup>1<\/sup>\u2013Cys<sup>6<\/sup> bildet einen 6-Reste-Makrozyklus mit einem 3-Reste-C-terminalen Ende; C-Terminus amidiert)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilisiertes Acetat-Salz (wei\u00df bis leicht gelbliches Pulver)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Reinheit<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC-best\u00e4tigt, COA auf Anfrage)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Lagerung<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilisat: 2\u20138 \u00b0C (K\u00fchlschrank) f\u00fcr Arbeitsvorrat; \u221220 \u00b0C zur Langzeitlagerung unge\u00f6ffneter Fl\u00e4schchen. Rekonstituiert: 2\u20138 \u00b0C, innerhalb von ~30 Tagen verwenden. Vor Licht sch\u00fctzen. Die rekonstituierte L\u00f6sung nicht einfrieren und auftauen.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>L\u00f6slichkeit<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Was ist Oxytocinacetat?<\/h2>\n<p><strong>Oxytocin Acetat<\/strong> is the acetate-salt form of oxytocin, a 9-amino-acid cyclic neuropeptide first isolated by Sir Henry Dale in 1906 and chemically synthesised by Vincent du Vigneaud in 1953 \u2014 the first peptide hormone ever produced by total synthesis, work that earned du Vigneaud the 1955 Nobel Prize in Chemistry. The acetate counterion is used in pharmaceutical-grade lyophilization because it improves long-term peptide stability and water solubility relative to free-base oxytocin without altering pharmacology \u2014 the acetate dissociates rapidly in physiological solution. The well-characterised sequence is CYIQNCPLG-NH<sub>2<\/sub> mit einer intramolekularen Disulfidbr\u00fccke zwischen Cys1 und Cys6, die einen 6-Rest-Makrozyklus und einen 3-Rest-C-terminalen Schwanz bildet. Molekulargewicht: 1007,19 Da (freie Base); empirische Formel C<sub>43<\/sub>H<sub>66<\/sub>N<sub>12<\/sub>O<sub>12<\/sub>S<sub>2<\/sub>. Oxytocin is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For related small-peptide CNS studies, see our <a href=\"https:\/\/medsbase.com\/de\/selank\/\">Selank<\/a> und <a href=\"https:\/\/medsbase.com\/de\/pt-141\/\">PT-141<\/a> Produktseiten. <\/p>\n<h2>Was Oxytocin unter Forschungspeptiden ungew\u00f6hnlich macht, ist seine<\/h2>\n<p>What makes oxytocin unusual among peptides is its <strong>als sowohl peripheres endokrines Hormon als auch zentraler Neuromodulator. Das gleiche Molek\u00fcl, das aus verschiedenen anatomischen Kompartimenten freigesetzt wird, erzeugt grundlegend unterschiedliche physiologische Effekte:<\/strong> sowohl als peripheres endokrines Hormon als auch als zentraler Neuromodulator. Dasselbe Molek\u00fcl, das aus verschiedenen anatomischen Kompartimenten freigesetzt wird, erzeugt grundlegend unterschiedliche physiologische Effekte:<\/p>\n<ul>\n<li><strong>Periphere endokrine Freisetzung \u2014 uterine und mamm\u00e4re Effekte<\/strong> \u2014 Oxytocin wird in magnozellul\u00e4ren Neuronen der Nuclei supraopticus und paraventricularis des Hypothalamus synthetisiert und aus dem Hypophysenhinterlappen in den systemischen Kreislauf freigesetzt. Peripheres Oxytocin bindet an OXTR-Rezeptoren auf der glatten Uterusmuskulatur (F\u00f6rderung der Wehent\u00e4tigkeit) und an myoepithelialen Zellen der Milchbl\u00e4schen (Ausl\u00f6sung des Milchspendereflexes). Die periphere Halbwertszeit ist aufgrund des raschen Abbaus durch Oxytocinase und andere Peptidasen kurz (~3\u20135 Minuten i.v.).<\/li>\n<li><strong>Zentrale Freisetzung \u2014 soziales, bindungsf\u00f6rderndes und stresspufferndes Verhalten<\/strong> \u2014 A separate population of parvocellular oxytocin neurons projects axonally into brain regions including the amygdala, nucleus accumbens, ventral tegmental area, and prefrontal cortex. Central oxytocin release does not enter systemic circulation and is not measured by plasma assays. In published studies it modulates pair-bonding, in-group affiliation, trust, fear extinction, and stress reactivity. The prairie-vole pair-bonding literature is the canonical mechanistic dataset for central oxytocin signalling.<\/li>\n<li><strong>Rezeptorpharmakologie und Signaltransduktion<\/strong> \u2014 Oxytocin wirkt auf einen einzigen G-Protein-gekoppelten Rezeptor (OXTR), der prim\u00e4r an G\u03b1<sub>q\/11<\/sub> koppelt, um Phospholipase C, IP<sub>3<\/sub>, und die Freisetzung von intrazellul\u00e4rem Kalzium in glatter Muskulatur. Im ZNS ist die OXTR-Signalgebung komplexer und umfasst G\u03b1<sub>und intrazellul\u00e4re Kalziumfreisetzung in glatter Muskulatur zu aktivieren. Im ZNS ist die OXTR-Signalgebung komplexer und umfasst G\u03b1<\/sub> coupling, modulation of GABAergic interneurons, and crosstalk with the closely-related vasopressin V1a receptor. Selective OXTR agonists and antagonists are heavily used in current studies to dissect oxytocin vs vasopressin contributions to behaviour.<\/li>\n<\/ul>\n<p>The intranasal administration route is one of the most-cited studies delivery methods because it produces measurable CNS effects on social behaviour without raising peripheral plasma oxytocin to physiologically meaningful levels. The exact mechanism by which intranasal oxytocin reaches CNS compartments \u2014 whether through olfactory and trigeminal nerve transport, cribriform plate diffusion, or a peripheral feedback signal \u2014 remains an active studies question. The behavioural effects are reproducible enough that intranasal administration has become the standard route in human and rodent oxytocin behavioural support. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Oxytocin Acetate is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Sozialverhalten und Paarbindung<\/strong> \u2014 Pr\u00e4rie-W\u00fchlmaus-Partnerpr\u00e4ferenztests, Partnerpr\u00e4ferenzbildung bei monogamen vs. polygamen W\u00fchlm\u00e4usen, soziales Erkennungsparadigma bei Nagetieren (Insel &amp; Hulihan, Behav Neurosci 1995; Young &amp; Wang, Nat Neurosci 2004)<\/li>\n<li><strong>Autism spectrum and social-cognition studies<\/strong> \u2014 preclinical models of social-deficit phenotypes, OXTR variant cohort studies, intranasal oxytocin behavioural endpoints; one of the most active areas of contemporary oxytocin clinical studies<\/li>\n<li><strong>Trust and cooperation behavioural support<\/strong> \u2014 \u00f6konomische Paradigmen des Vertrauensspiels, kooperative Entscheidungsfindung unter Unsicherheit; Modulation von In-Group vs. Out-Group-Bias<\/li>\n<li><strong>Stress, Angst und Furchtl\u00f6schung<\/strong> \u2014 amygdala-dependent fear conditioning, stress-induced HPA-axis activation, cortisol response modulation in published studies<\/li>\n<li><strong>M\u00fctterliches Verhalten und elterliche F\u00fcrsorge<\/strong> \u2014 postpartum maternal-behaviour induction in rodents, paternal-care studies in monogamous vole species, alloparental behaviour<\/li>\n<li><strong>Reproductive physiology studies<\/strong> \u2014 uterine contractility assays, mammary myoepithelial-cell studies, labour and parturition mechanism studies<\/li>\n<li><strong>Wundheilung und Geweberegeneration<\/strong> \u2014 OXTR expression on dermal fibroblasts and keratinocytes; emerging studies on local oxytocin signalling in cutaneous wound repair<\/li>\n<li><strong>Comparative neuropeptide studies<\/strong> \u2014 Benchmarking gegen Vasopressin (eng verwandtes 9-aa zyklisches Neuropeptid mit einer Aminos\u00e4urendifferenz) und gegen andere kleine ZNS-aktive Peptide wie <a href=\"https:\/\/medsbase.com\/de\/selank\/\">Selank<\/a>.<\/li>\n<\/ul>\n<p>F\u00fcr einen breiteren Kontext, wo Oxytocin in der Landschaft der kleinen Peptid-Neuromodulatoren einzuordnen ist, siehe <a href=\"https:\/\/medsbase.com\/de\/selank\/\">Selank<\/a> (anxiolytisches Heptapeptid), <a href=\"https:\/\/medsbase.com\/de\/pt-141\/\">PT-141<\/a> (ZNS-aktiver Melanocortin-Agonist), und <a href=\"https:\/\/medsbase.com\/de\/semax\/\">Semax<\/a> (nootropes Heptapeptid). Durchst\u00f6bern Sie das gesamte <a href=\"https:\/\/medsbase.com\/de\/peptides\/\">Peptid-Katalog<\/a> f\u00fcr verwandte Verbindungen. <\/p>\n<h2>Verf\u00fcgbare St\u00e4rken und Konzentrationen<\/h2>\n<p>MedsBase stocks Oxytocin Acetate in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Vial-St\u00e4rke<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typischer Anwendungsfall<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Packungsgr\u00f6\u00dfen<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, intranasal-vehicle formulation, behavioural-test protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 oder 30 Vials<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended-cycle studies, lowest per-mg cost, multi-cohort behavioural studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 oder 30 Vials<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized acetate-salt powder, 99%+ HPLC purity). Because oxytocin&#8217;s dose range is in the low-microgram-per-administration regime, a single 5\u00a0mg vial supports many weeks of behavioural support at typical intranasal doses (24\u00a0IU \u2248 40\u00a0mcg per administration in human studies, with rodent doses scaled lower). <\/p>\n<h2>Vergleich \u2014 Oxytocinacetat vs. Selank<\/h2>\n<p>Oxytocin und <a href=\"https:\/\/medsbase.com\/de\/selank\/\">Selank<\/a> are both small CNS-active peptides used in behavioural and mood-axis studies, but they target different receptors and behavioural domains. They are sometimes compared in studies because both are intranasally bioavailable and both produce measurable behavioural effects in published rodent and human studies despite being structurally and pharmacologically unrelated. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Kriterium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Oxytocin Acetat<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Selank<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>L\u00e4nge<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">9 Aminos\u00e4uren (zyklisches Nonapeptid)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 Aminos\u00e4uren (lineares Heptapeptid)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Struktur<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Disulfidbr\u00fccken-Makrozyklus<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Linear mit amidierter C-Terminus<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Prim\u00e4rer Rezeptor<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">OXTR (G-Protein-gekoppelt)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Nicht-klassisch (GABA-Modulation, BDNF)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Verhaltenssignal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Soziale Bindung, Vertrauen, affiliatives Verhalten<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Anxiolytisch, Stressresistenz<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typical dose (intranasal)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">24\u201340 IE (~40\u201365 \u00b5g)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">300\u2013900 \u00b5g<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Plasmahalbwertszeit<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~3\u20135 min (i.v.)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~15\u201330 min (intranasal)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Klinisch zugelassene Anwendung<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Weheneinleitung, postpartale Blutung<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Anxiolytikum (nur in Russland)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For behavioural-stacking, the two peptides have non-overlapping mechanisms (oxytocin acts on its own GPCR; Selank acts via GABA\/BDNF modulation), so co-administration is not pharmacologically redundant. Study protocols studying stress and social behaviour as joint endpoints sometimes use both arms. <\/p>\n<h2>Lagerung und Rekonstitution<\/h2>\n<p><strong>Vor der Rekonstitution:<\/strong> Lagern Sie lyophilisierte Fl\u00e4schchen kurzzeitig gek\u00fchlt bei 2\u20138 \u00b0C in der Originalverpackung als Arbeitsvorrat. F\u00fcr unge\u00f6ffnete Langzeitlagerung einfrieren bei \u221220 \u00b0C. Lyophilisiertes Oxytocinacetat ist unter K\u00fchlung bis zu 24 Monate und bei \u221220 \u00b0C bis zu 36 Monate stabil. Vermeiden Sie Gefrier-Tau-Zyklen beim lyophilisierten Pulver. Die Acetat-Salz-Form ist hygroskopisch stabiler als die freie Base, aber Fl\u00e4schchen sollten dennoch vor Luftfeuchtigkeit gesch\u00fctzt werden. <strong>Rekonstitutionsverfahren:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 5.0\u00a0mL of bacteriostatic water yields a 1\u00a0mg\/mL working concentration; 0.04\u00a0mL delivers a 40\u00a0mcg dose (~24\u00a0IU). Swirl gently \u2014 do <strong>nicht<\/strong> shake \u2014 and allow 2\u20135 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100\u00a0\u03bcL per pump. <strong>gek\u00fchlt bei 2\u20138 \u00b0C lagern und innerhalb von 30 Tagen verwenden. Rekonstituierte L\u00f6sung nicht einfrieren.<\/strong> Im K\u00fchlschrank bei 2\u20138 \u00b0C lagern und innerhalb von 30 Tagen verwenden, um die optimale Stabilit\u00e4t zu gew\u00e4hrleisten. Die rekonstituierte L\u00f6sung nicht einfrieren \u2013 Gefrier-Tau-Zyklen beeintr\u00e4chtigen die Peptidintegrit\u00e4t und st\u00f6ren die Cys1\u2013Cys6-Disulfidbindung. Jedes Fl\u00e4schchen mit Tr\u00fcbung, Ausf\u00e4llung oder Verf\u00e4rbung verwerfen. <\/p>\n<h2 id=\"faqs\">H\u00e4ufig gestellte Fragen<\/h2>\n<h3>What is Oxytocin Acetate used for in studies?<\/h3>\n<p>Oxytocin Acetate is used in studies investigating social behaviour and pair-bonding, autism spectrum and social cognition, trust and cooperation paradigms, stress and fear extinction, maternal and parental care, reproductive physiology, and wound healing. It is one of the most extensively studied neuropeptides in the published literature and serves as the canonical OXTR-axis compound. The pharmaceutical-grade oxytocin acetate sold here is <strong>nicht<\/strong> FDA-approved for non-clinical human use and is supplied strictly for clinical studies. <\/p>\n<h3>Was ist der Unterschied zwischen Oxytocinacetat und freier Oxytocinbase?<\/h3>\n<p>The acetate counterion does not alter pharmacology \u2014 it dissociates rapidly in physiological solution. The acetate salt is used in pharmaceutical-grade peptide lyophilization because it improves long-term peptide stability, reduces hygroscopicity, and improves aqueous solubility relative to free-base oxytocin. All published behavioural and endocrine effects of oxytocin apply to the acetate salt at equivalent oxytocin content. <\/p>\n<h3>Wie unterscheidet sich Oxytocin von Selank?<\/h3>\n<p>Both are small CNS-active peptides used in behavioural support, but they target different receptors and behavioural domains. Oxytocin is a 9-amino-acid disulfide-bridged macrocyclic peptide that binds the OXTR G-protein-coupled receptor, with primary signal in social bonding and trust paradigms. Selank is a 7-amino-acid linear heptapeptide that acts via GABA modulation and BDNF expression, with primary signal in anxiolysis and stress resilience. The two are pharmacologically unrelated. <\/p>\n<h3>What is the typical Oxytocin dose?<\/h3>\n<p>Published human intranasal protocols typically use 24\u201340\u00a0IU per administration (1\u00a0IU \u2248 1.7\u00a0mcg, so 24\u00a0IU \u2248 40\u00a0mcg). Rodent doses are scaled lower in absolute mass but higher in mg\/kg. A 5\u00a0mg vial reconstituted with 5.0\u00a0mL bacteriostatic water yields 1\u00a0mg\/mL \u2014 40\u00a0mcg per 0.04\u00a0mL. <\/p>\n<h3>Ist Oxytocinacetat FDA-zugelassen?<\/h3>\n<p>Pharmaceutical injectable oxytocin (Pitocin, Syntocinon) is FDA-approved for specific obstetric indications \u2014 labour induction, postpartum haemorrhage control, and milk-letdown facilitation \u2014 manufactured to GMP standards by approved pharmaceutical manufacturers. <\/p>\n<h3>Wie sollte Oxytocinacetat gelagert werden?<\/h3>\n<p>Lyophilisierte Fl\u00e4schchen: gek\u00fchlt bei 2\u20138 \u00b0C f\u00fcr kurzfristige Arbeitsvorr\u00e4te oder \u221220 \u00b0C f\u00fcr die Langzeitlagerung unge\u00f6ffneter Fl\u00e4schchen. Rekonstituierte L\u00f6sung: gek\u00fchlt bei 2\u20138 \u00b0C, innerhalb von 30 Tagen verwenden. Rekonstituierte L\u00f6sung nicht einfrieren \u2014 Gefrier-Tau-Zyklen degradieren das Peptid und k\u00f6nnen die Disulfidbr\u00fccke zerst\u00f6ren. Immer vor direktem Licht sch\u00fctzen. <\/p>\n<h3>Wie rekonstituiere ich Oxytocinacetat?<\/h3>\n<p>Befolgen Sie das oben beschriebene Rekonstitutionsverfahren. Geben Sie bakterienstatisches Wasser an der Seitenwand des Fl\u00e4schchens hinzu (nicht auf den lyophilisierten Kuchen), schwenken Sie vorsichtig und lassen Sie 2\u20135 Minuten zur vollst\u00e4ndigen Aufl\u00f6sung. Sch\u00fctteln Sie <strong>nicht<\/strong> Sch\u00fctteln Sie das Fl\u00e4schchen nicht \u2014 kr\u00e4ftiges Sch\u00fctteln kann die Disulfidbindung zerst\u00f6ren. Eine korrekt rekonstituierte L\u00f6sung ist klar und farblos. F\u00fcr ein 5 mg Fl\u00e4schchen + 5,0 mL L\u00f6sungsmittel betr\u00e4gt die Arbeitskonzentration 1 mg\/mL. <\/p>\n<h3>Welche St\u00e4rken f\u00fchrt MedsBase?<\/h3>\n<p>MedsBase carries Oxytocin Acetate in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Can Oxytocin be administered intranasally in studies?<\/h3>\n<p>Yes \u2014 intranasal administration is one of the most-cited studies delivery routes for oxytocin behavioural studies. Intranasal oxytocin produces measurable CNS effects on social behaviour, trust, and stress reactivity without raising peripheral plasma oxytocin to physiologically meaningful levels. The exact mechanism of CNS access remains an active studies question (olfactory and trigeminal nerve transport, cribriform plate diffusion, or peripheral feedback). Subcutaneous and intracerebroventricular routes are also documented in rodent studies. <\/p>\n<h3>Wie ist die Halbwertszeit von Oxytocin?<\/h3>\n<p>In published studies, oxytocin has a plasma half-life of approximately 3\u20135 minutes following intravenous administration. The short peripheral half-life is due to rapid metabolism by oxytocinase (also called cystinyl aminopeptidase) and other peptidases. Behavioural effects following intranasal administration outlast plasma clearance because central oxytocin compartments are distinct from peripheral circulation. <\/p>\n<h3>Warum ist die Disulfidbr\u00fccke wichtig?<\/h3>\n<p>Die Cys1\u2013Cys6-Disulfidbindung fixiert Oxytocin in der f\u00fcr die Rezeptorbindung erforderlichen zyklischen Konformation. Die Reduktion der Disulfidbindung wandelt Oxytocin in eine inaktive lineare Form um \u2013 deshalb vermeiden Rekonstitutionsverfahren ausdr\u00fccklich starkes Sch\u00fctteln und Gefrier-Tau-Zyklen, die die Br\u00fccke st\u00f6ren und die Peptidaktivit\u00e4t beeintr\u00e4chtigen k\u00f6nnen. Das eng verwandte Neuropeptid Vasopressin weist die gleiche Disulfidbr\u00fccken-Architektur auf, mit nur einem Aminos\u00e4ureunterschied an Position 3 (Phe in Vasopressin vs. Ile in Oxytocin). <\/p>\n<h3>Does Oxytocin cause side reported effects?<\/h3>\n<p>The most consistent finding in oxytocin is dose-dependence of behavioural effects \u2014 the response is not monotonic at high doses, and very large doses can produce paradoxical effects. Acute peripheral effects can include uterine contraction (relevant in pregnancy study models) and modest vasoactive effects at supraphysiological doses. Long-term behavioural support has reported context-dependent effects \u2014 e.g., increased in-group affiliation can be accompanied by increased out-group bias in some social-cognition paradigms. <\/p>\n<h3>How long does Oxytocin take to show effects in preclinical studies?<\/h3>\n<p>Acute behavioural effects on social-recognition, partner-preference, and trust-game paradigms are detectable within 30\u201360 minutes of intranasal administration in human and rodent studies. Peripheral effects (uterine contraction, milk-ejection) occur within seconds of intravenous administration due to direct OXTR coupling to PLC\/IP<sub>3<\/sub>Kann ich Oxytocinacetat f\u00fcr den internationalen Versand bestellen?<sup>2+<\/sup> Ja. MedsBase versendet Oxytocinacetat weltweit \u00fcber unser spezielles Peptid-Versandnetzwerk. Bestellungen ausschlie\u00dflich mit Peptiden qualifizieren sich f\u00fcr unseren eigenst\u00e4ndigen Peptidversandservice. Alle Bestellungen werden in temperaturkontrollierter Verpackung mit vollst\u00e4ndiger Sendungsverfolgung versandt und sind durch unsere. <\/p>\n<h3>Kann ich Oxytocinacetat f\u00fcr den internationalen Versand bestellen?<\/h3>\n<p>Ja. MedsBase versendet Oxytocin Acetat weltweit \u00fcber unser spezielles Peptid-Versandnetzwerk. Bestellungen, die nur Peptide enthalten, qualifizieren sich f\u00fcr unseren separaten Peptid-Versandservice. Alle Sendungen werden in temperaturkontrollierter Verpackung mit vollst\u00e4ndiger Sendungsverfolgung verschickt und sind abgedeckt durch unser <a href=\"https:\/\/medsbase.com\/de\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for CNS, Behavioural, and Affective Studies<\/h2>\n<ul>\n<li><a href=\"\/de\/selank\/\"><strong>Selank<\/strong><\/a> \u2014 Anxiolytic heptapeptide tuftsin analog \u2014 GABA\/BDNF stress resilience<\/li>\n<li><a href=\"\/de\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Russisch entwickeltes nootropes Heptapeptid \u2014 Melanocortin- und dopaminerge Modulation<\/li>\n<li><a href=\"\/de\/pt-141\/\"><strong>PT-141 (Bremelanotid)<\/strong><\/a> \u2014 Melanocortin receptor agonist \u2014 CNS-active small peptide for sexual-behaviour studies<\/li>\n<li><a href=\"\/de\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/de\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tissue-recovery<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Weiterf\u00fchrende Literatur<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore CNS-active peptides<\/strong><\/p>\n<p style=\"margin: 0;\">Durchst\u00f6bern Sie das gesamte Sortiment <a href=\"https:\/\/medsbase.com\/de\/peptides\/\"><strong>Peptid-Katalog<\/strong><\/a>, mit verwandten Verbindungen einschlie\u00dflich <a href=\"https:\/\/medsbase.com\/de\/selank\/\">Selank<\/a> for anxiolytic GABA-axis studies, <a href=\"https:\/\/medsbase.com\/de\/semax\/\">Semax<\/a> for nootropic melanocortin-axis studies, and <a href=\"https:\/\/medsbase.com\/de\/pt-141\/\">PT-141<\/a> for melanocortin sexual-behaviour studies.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 9-Aminos\u00e4uren-zyklisches Neuropeptid<br \/>\n\u2705 OXTR-Rezeptoragonist<br \/>\n\u2705 Social-bonding &amp; affiliative behavioural support<br \/>\n\u2705 Intranasal bioverf\u00fcgbares Peptid<br \/>\n\u2705 Acetat-Salzform \u2014 verbesserte Stabilit\u00e4t<\/p>\n<p><strong>Oxytocin Acetat<\/strong> enth\u00e4lt synthetische Peptidverbindung.<\/p>","protected":false},"featured_media":70970,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6274,5441],"class_list":["post-70705","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-oxytocin","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product\/70705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/comments?post=70705"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media\/70970"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media?parent=70705"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_brand?post=70705"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_cat?post=70705"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_tag?post=70705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}